Tricuspid / Pulmonary valve

An 84-year-old female patient with severe tricuspid valve regurgitation (TR) and progressive right-sided heart failure signs is referred for diagnosis and treatment. Transoesophageal echocardiography (TEE) reveals isolated torrential TR (5/5) with a large coaptation gap size and tethered leaflets. How would you treat this patient?

An 87-year-old male patient with severe tricuspid regurgitation, a history of pacemaker implantation, and atrial fibrillation seeks advanced treatment options to improve his declining exercise capacity and daily activities.

#div-gpt-pcro_sidebar_topic {display:none !important;}

In this analysis, the 3-year outcomes of the TRILUMINATE study are presented, evaluating the long-term effectiveness of the TriClip T-TEER system on TR reduction, right ventricular remodeling, quality of life, and heart failure symptoms.

Alex Sticchi provides his take on the results of the TRISCEND II trial presented by Susheel K. Kodali and Suzanne V. Arnold at TCT 2024 in Washington.

Also watch the interview with Susheel K. Kodali

Elad Asher provides his take on the PEERLESS trial presented by Wissam A. Jaber at TCT 2024 in Washington.

Thanks to the contribution of a team of interventional cardiologists from around the globe, get the international perspective on Late-breaking Clinical Trials and Science released at TCT 2024 - check out the list below.

Immerse yourself in this captivating session featuring selected clinical case submissions from the AICT-AsiaPCR 2024 conference. Explore a wide range of interventional challenges, including device closure of ruptured sinus of Valsalva aneurysm, balloon valvotomy during pregnancy in a double orifice mitral valve, and unusual femoral complications....

Watch the replay of this webinar with J. Dreyfus, A. Duncan, P. Lurz and V. Rudolph to understand the pros and cons of TTVR and much more!

Alex Sticchi provides his take on the TRIGISTRY study presented by Julien Dreyfus at the ESC Congress 2024 in London.

Simultaneous publication in European Heart Journal, ehae578

The review aims to address the unmet needs in heart failure (HF) management, particularly in patients where structural heart disease coexists with HF and limits the effectiveness of guideline-directed medical therapy (GDMT).